Evidence map›Paper›PMID 38025656›Full record

ArticleHealth equity2023

A Call to Improve Usability, Accuracy, and Equity of Self-Testing for COVID-19 and Other Rapid Diagnostic Tests.

Paul K Drain, Alexandra K Adams, Larry Kessler, Matthew Thompson

Abstract read
In one paragraph

Article in Health equity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Public engagement with consumer sleep technology for obstructive sleep apnea screening: implications for equity, access, and practice.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul K DrainDepartment of Global Health and Medicine, University of Washington, Seattle, Washington, USA.
Alexandra K AdamsCenter for American Indian and Rural Health Equity (CAIRHE), Montana State University, Bozeman, Montana, USA.
Larry KesslerDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.
Matthew ThompsonDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.

Funding

Translational Biomarkers CoreP20GM104417 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI MARGETTS, MIRANDA L · 2014 to 2023
$23.1M
NIGMS NIH HHS P20 GM104417
6 · The paper itself

Abstract

The increasing availability of rapid diagnostic self-tests (RDSTs) for COVID-19 has played an important and increasing role during the pandemic. However, for many underserved communities, RDSTs potential benefits are offset by problems with usability, accuracy, and equity. Given the increased need for and interest in home testing for acute and chronic diseases, including COVID-19, this piece offers ways that regulatory agencies, federal public health agencies, and test developers should engage with diverse communities to ensure equity throughout test development, implementation, and evaluation. Such engagement will ensure maximum personal and public health benefits for current and future RDSTs under real-world conditions.

Indexed as

COVID-19COVID-19 self-testingrapid diagnostic testingunderserved populations

Identifiers

PMID38025656
PMCPMC10664557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.